ScholarIQanswers from OpenAlex

Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study

PaperCitations, authors & open-access status

Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study have?

ScholarIQcitation count

Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study has 92 citations in the OpenAlex counts ScholarIQ stores.

When was Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study published?

ScholarIQyear

Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study has 2013 year in the ScholarIQ index.

What is the open-access status of Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study?

ScholarIQoa status

Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study has bronze oa status in the ScholarIQ index.

What is the DOI of Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study?

ScholarIQdoi

The DOI for Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study is on the source record.

What is the PMID of Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study?

ScholarIQpmid

The PMID for Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study is on the source record.

What is the OpenAlex record for Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study?

ScholarIQopenalex

The OpenAlex for Levosimendan in Acute Heart Failure Following Primary Percutaneous Coronary Intervention-Treated Acute ST-Elevation Myocardial Infarction. Results from the LEAF Trial: A Randomized, Placebo-Controlled Study is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial